4Forones NM, Tanaka M. CEA and CA 19-9 as prognostic indexes in colorectal cancer [ J]. Hepatogastroenterology, 1999,46 ( 26 ) :905- 908.
5Fukunaga H, Sekimoto M, Ikeda M, et al. Fusion image of positron emission tomography and computed tomography for the diagnosis of local recurrence of rectal cancer [J]. Ann Surg Oncol, 2005", 12 (7) :561-569.
6Weitz J, Koch M, Debus J, et al. Colorectal cancer [ J ].Lancet, 2005, 365(9454) : 153-165.
7Gravalos C, Garcia-Escobar I , Garcia-Alfonso P, et al.Adjuvant chemotherapy for stages Ⅱ, Ⅲ and Ⅳof colon cancer [ J ].Clin Transl Oncol, 2009,11 ( 8 ) : 526-533.
8Siegel R,Naishadham D,Jemal A. Cancer statistics,2012 [J].CA Cancer J Clin, 2012,62( 1 ) : 10-29.
9Cortinovis D, Bajetta E,Di Bartolomeo M, et al. Raltitrexed plus ox- aliplatin in the treatment of metastatic colorectal cancer E J ]. Tumori, 2004,90( 2): 186-191.
10Cascinu S,Graziano F,Ferrau F,et al. Raltitrexed plus oxaliplatin(TOMOX) as first-line chemotherapy for metastatic colorectal can- cer. A phase Ⅱ study of the Italian Group for the Study of Gastroin- testinal Tract Carcinomas (GISCAD) [ J ]. Ann Oncol, 2002,13 ( 5 ) : 716-720.
